Latest from Our Blog

Atara Biotherapeutics Launches Next-Gen Immunotherapy Targeting Mesothelin in Mesothelioma Cancers

Atara Biotherapeutics announced May 15 that an abstract that describes the preclinical safety, enhanced functional characteristics and anti-tumor efficacy of ATA2271 – a next-gen autologous chemeric antigen receptor (CAR) T cell therapy targeting mesothelin – was chosen for a poster presentation at the 2nd American Association for Cancer Research (AACR) Virtual Annual Meeting 2020. The… Read More »

Teacher in Philadelphia with Mesothelioma Catches City’s Attention

Mesothelioma diagnoses normally do not get headlines in local newspapers, especially in large cities such as Philadelphia. But that is what happened recently in The City of Brotherly Love as the Philadelphia Inquirer has been following the mesothelioma case of Lea DiRusso. DiRusso is a 51-year-old who worked for almost 30 years as a teacher… Read More »

Artificial Intelligence Beats Radiologists in Detecting Lung Cancer

Scientists recently conducted a clinical study where they trained an artificial intelligence (AI) deep learning tool to look for lung cancer tumors in CT scans. The algorithm’s evaluation was compared with those of six radiologists. The results indicated that the AI was better and more accurate in detecting lung cancer when CT imaging was unavailable.… Read More »

United Kingdom Oncologist Proposes Novel Treatment for Mesothelioma

Medical oncologist Angus Dalgleish, M.D., never did prefer the standard treatments for pleural mesothelioma, even when he had recommended them to patients in the past. He thinks there are now better options. Dalgleish, who is a physician at St. George’s Hospital at the University of London, recently released a case study that detailed a novel… Read More »

New Clinical Study Finds Connection Between Talc and Malignant Mesothelioma

Thousands of personal injury lawsuits have been filed by victims of malignant mesothelioma against companies that sell and manufacture talc-based products, such as Johnson & Johnson, Colgate Palmolive, and Avon. But the corporate line has been that their talc is not tainted with asbestos. They further argue that talc by itself does not cause asbestos… Read More »

Novocure Unveils Promising Mesothelioma Treatment Device

There is a new treatment device for mesothelioma from Novocure called the NovoTFF-100L System, better known as Optune Lua. FDA approved the medical device almost a year ago. (mesotheliomaguide.com) The news of Optune Lua could be big news for mesothelioma patients, who usually do not live beyond a year after a mesothelioma diagnosis. While many… Read More »

New Asbestos Cancer Drug Pemfexy Gets FDA Approval

FDA gave final approval for the chemotherapy drug Pemfexy (pemetrexed) after several years of legal battles. The drug was patented by Eagle Pharmaceuticals, based in New Jersey, to treat malignant mesothelioma, as well as metastatic nonsquamous non-small cell lung cancer. The approved injection chemotherapy drug will serve as an alternative to standard medication Alimta (also… Read More »

Jury Orders J&J to Pay $750 Million in Talc Mesothelioma Case

A state court in New Jersey has ordered J&J to pay $750 million in damages to four people who claimed toxic asbestos in the firm’s talcum powder products caused their mesothelioma. The judge in the asbestos cancer case stated she would ower the damages. But the amount is still the most awarded yet to plaintiffs… Read More »

New Study Shows Why Asbestos Exposure Causes Pleural Mesothelioma

A recent study by the Swiss National Science Foundation has explicitly shown how asbestos fibers can cause cancer to develop in the body. The information is useful for clinicians who want more effective therapies to treat mesothelioma and also is of use in personal injury lawsuits so that plaintiffs’ attorneys have more ammunition in their… Read More »

American Cancer Society Releases Insights from 2019

The American Cancer Society recently released its 2019 year-in-review data, which revealed insights from cancer research it conducted throughout the year. Among top stories for the year, cancer researchers found a connection between cancer and obesity. They also found that exercise is of great value during the cancer journey of the patient. Clinical studies also… Read More »

Depression After Being Diagnosed with Mesothelioma: Women Have Most Risk

White women have a higher chance to have depression after being diagnosed with mesothelioma, a rare cancer of the lung lining caused by asbestos exposure. (Survivingmesothelioma.com) That conclusion came this week from researchers based at the University of Florida. The team looked at the cases of 120,000 people with late-stage mesothelioma. While all patients with… Read More »

San Diego Firefighters Sue Over Mesothelioma and Other Illnesses

After revelations that the city of San Diego had put them at higher risk for mesothelioma and other diseases related to asbestos exposure, hundreds of firefighters and other employees in the department filed a negligence claim on July 2, holding the city responsible for possible medical damages. This issue came to light after an investigation… Read More »

NY Jury Orders J&J to Pay $325 Million to Mesothelioma Victim

In one of the biggest verdicts to come down in a large number of mesothelioma lawsuits that have been filed against Johnson & Johnson, a state jury in New York ordered the company to pay a woman suffering from mesothelioma $300 million in punitive damages. (mesothelioma.net) This means Donna Olson and her husband will have… Read More »

Clinical Study Starts to Develop Breath Test for Early Detection of Mesothelioma

A doctor with more than 30 years of experience fighting asbestos-related diseases is the lead investigator in a new clinical trial of breath-based biomarkers that may say lives through early detection of mesothelioma. (asbestos.com) According to Michael Harbut, MD, the new clinical study has great significance for the early detection of mesothelioma and could become… Read More »

New Radiotherapy Treatment Can Double Two-Year Survival for Mesothelioma

A new radiotherapy treatment can double the odds of surviving two or more years with pleural mesothelioma, according to a study performed by Dr. Marco Trovo at University Hospital of Udine in Italy. (asbestos.com) Trovo is the top author of a mesothelioma treatment study that involved 109 patients treated for malignant mesothelioma from 2014 to… Read More »

New EPA Rule Shows Strong Resistance to Need for Ban on Asbestos

As of 2019, asbestos still is not banned in the US, even with the many warnings and concerns of experts, scientists and advisors. It is well known throughout the world of science and medicine that asbestos causes many serious diseases, such as malignant mesothelioma and asbestosis. The EPA has established certain rules and regulations to… Read More »

Study Finds Elderly Mesothelioma Patients Denied Critical Survival Time

Almost 66% of elderly patients diagnosed with mesothelioma are passing away without receiving any sort of cancer-related treatments that could boost their survival. According to recent data, median survival for mesothelioma patients 80 years and older is just 4.1 months. The Annals of Surgical Oncology recently published the study, which was written and compiled by… Read More »

High-Dose Radiotherapy Increases Survival Rate in Mesothelioma

New clinical studies indicate that treatment with high doses of radiotherapy could greatly boost survival for patients with mesothelioma. New results from a clinical trial that was randomized show that patients who got aggressive radiotherapy were two times as likely to be alive after two years compared to patients who only got palliative radiotherapy; the… Read More »

Palliative Radiotherapy for Mesothelioma Produces Substantial Treatment Response

Physicians in Pennsylvania may possibly have found a way to increase the effectiveness of new type of palliative radiotherapy for pleural mesothelioma. Palliative radiotherapy is an important method of treatment to help people with mesothelioma symptoms. It is not expected, however, for doctors to treat mesothelioma with palliative radiotherapy. (survivingmesothelioma.com) However, researchers at the University… Read More »

Chemoimmunotherapy Being Hailed as the Next Frontier for Mesothelioma Cancer Treatment

According to Australian doctors recently, chemotherapy and immunotherapy are the next frontier for the treatment of deadly mesothelioma cancer. The study in which they made this bold statement was the medical journal Expert Opinions in Biological Therapy. The doctors reviewed several mesothelioma clinical studies from 2016 to 2018. (survivingmesothelioma.com) Some of the studies were centered… Read More »

Curis Completes Mesothelioma Enrollment in CA-170 Study

Curis, Inc., a biotechnology company that centers on developing new and innovative therapeutics to treat cancer, announced May 6 that its Phase 1 study of CA-170 has reached the desired target enrollment of patients with mesothelioma cancer. Curis began enrolling and dosing patients in the clinical study at the beginning of 2019. (finance.yahoo.com) The company… Read More »

Ford Motor Company Attempts to Evade $9.1 Million Mesothelioma Payout

Ford Motor Company attempted this month to evade a $9.1 million mesothelioma judgement. However, the judge on the case was not sympathetic to the company’s arguments. Delaware Superior Court Judge Ferris W. Wharton rejected arguments from the automotive company that it was not treated well in court and deserved to have a new trial set.… Read More »